171 related articles for article (PubMed ID: 27242669)
21. Outcome of surgery for toxic goitres in Maiduguri: a single teaching hospital's perspective.
Ali N; Madziga AG; Dogo D; Gali BM; Gadzama AA
Niger J Clin Pract; 2012; 15(3):280-4. PubMed ID: 22960961
[TBL] [Abstract][Full Text] [Related]
22. [The surgical treatment of the nodular goiter].
Pelizzo MR; Toniato A; Piotto A; Pagetta C; Ide EC; Boschin IM; Bernante P
Ann Ital Chir; 2008; 79(1):13-6. PubMed ID: 18572733
[TBL] [Abstract][Full Text] [Related]
23. Identification of constitutively activating somatic thyrotropin receptor mutations in a subset of toxic multinodular goiters.
Holzapfel HP; Führer D; Wonerow P; Weinland G; Scherbaum WA; Paschke R
J Clin Endocrinol Metab; 1997 Dec; 82(12):4229-33. PubMed ID: 9398745
[TBL] [Abstract][Full Text] [Related]
24. Evolution of autonomy in idiopathic non-toxic goiter, evaluated by regional suppressibility of 99mTc-uptake and TSH response to TRH.
Dige-Petersen H; Clemmensen OJ; Hummer L
Nuklearmedizin; 1976 Aug; 15(4):197-200. PubMed ID: 824625
[TBL] [Abstract][Full Text] [Related]
25. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
Mojsak MN; Abdelrazek S; Szumowski P; Rogowski F; Sykała M; Kostecki J; Kociura-Sawicka A; Jurgilewicz D; Myśliwiec J
Nucl Med Rev Cent East Eur; 2016; 19(1):3-11. PubMed ID: 26841373
[TBL] [Abstract][Full Text] [Related]
26. Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients.
Cohen O; Ilany J; Hoffman C; Olchovsky D; Dabhi S; Karasik A; Goshen E; Rotenberg G; Zwas ST
Eur J Endocrinol; 2006 Feb; 154(2):243-52. PubMed ID: 16452537
[TBL] [Abstract][Full Text] [Related]
27. Human recombinant TSH preceding a therapeutic dose of radioiodine for multinodular goiters has no significant effect in the surge of TSH-receptor and TPO antibodies.
Rubio IG; Perone BH; Silva MN; Knobel M; Medeiros-Neto G
Thyroid; 2005 Feb; 15(2):134-9. PubMed ID: 15753672
[TBL] [Abstract][Full Text] [Related]
28. [Multinodular diving goiters: 100 cases in Morocco].
Tajdine MT; Lamrani M; Serhane K; Achour A; Benariba F; Daali M
Sante; 2005; 15(4):247-52. PubMed ID: 16478704
[TBL] [Abstract][Full Text] [Related]
29. Management of simple nodular goiter: current status and future perspectives.
Hegedüs L; Bonnema SJ; Bennedbaek FN
Endocr Rev; 2003 Feb; 24(1):102-32. PubMed ID: 12588812
[TBL] [Abstract][Full Text] [Related]
30. Management of multinodular goiter in Germany (Papillon 2005): do the approaches of thyroid specialists and primary care practitioners differ?
Dietlein M; Wegscheider K; Vaupel R; Schmidt M; Schicha H
Nuklearmedizin; 2007; 46(3):65-75. PubMed ID: 17549317
[TBL] [Abstract][Full Text] [Related]
31. Total thyroidectomy for benign thyroid disorders in an endemic region.
Mishra A; Agarwal A; Agarwal G; Mishra SK
World J Surg; 2001 Mar; 25(3):307-10. PubMed ID: 11343181
[TBL] [Abstract][Full Text] [Related]
32. Radioiodine for nontoxic multinodular goiter.
Huysmans D; Hermus A; Edelbroek M; Barentsz J; Corstens F; Kloppenborg P
Thyroid; 1997 Apr; 7(2):235-9. PubMed ID: 9133693
[TBL] [Abstract][Full Text] [Related]
33. TSH-receptor autoantibodies - differentiation of hyperthyroidism between Graves' disease and toxic multinodular goitre.
Wallaschofski H; Kuwert T; Lohmann T
Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):171-4. PubMed ID: 15127319
[TBL] [Abstract][Full Text] [Related]
34. The majority of Danish nontoxic goitre patients are ineligible for Levothyroxine suppressive therapy.
Fast S; Bonnema SJ; Hegedüs L
Clin Endocrinol (Oxf); 2008 Oct; 69(4):653-8. PubMed ID: 18363890
[TBL] [Abstract][Full Text] [Related]
35. Levothyroxine suppressive therapy in the medical management of nontoxic benign multinodular goiter.
Celani MF
Exp Clin Endocrinol; 1993; 101(5):326-32. PubMed ID: 8299711
[TBL] [Abstract][Full Text] [Related]
36. The medical treatment of non-toxic goiter: several questions remain.
Koutras DA
Thyroidology; 1993 Aug; 5(2):49-55. PubMed ID: 7522531
[TBL] [Abstract][Full Text] [Related]
37. Approach to management of the patient with primary or secondary intrathoracic goiter.
Hegedüs L; Bonnema SJ
J Clin Endocrinol Metab; 2010 Dec; 95(12):5155-62. PubMed ID: 21131536
[TBL] [Abstract][Full Text] [Related]
38. [Role of total thyroidectomy in the treatment of multinodular goiter].
Rodier JF; Janser JC; Rodier D
J Chir (Paris); 1991 Oct; 128(10):403-8. PubMed ID: 1761588
[TBL] [Abstract][Full Text] [Related]
39. Combination of Ultrasound-Guided Percutaneous Microwave Ablation and Radioiodine Therapy in Benign Thyroid Disease: A 3-Month Follow-Up Study.
Korkusuz H; Happel C; Koch DA; Gruenwald F
Rofo; 2016 Jan; 188(1):60-8. PubMed ID: 26566268
[TBL] [Abstract][Full Text] [Related]
40. [Thyroid diseases in sub-Saharan Africa].
Sidibé el H
Sante; 2007; 17(1):33-9. PubMed ID: 17897900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
